BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• FDA

  Takeda Pharmaceutical Co. Ltd. Wins FDA Approval for New Way to Adminster Velcade to Patients

  January 24, 2012

   · 

  6 min read
• BioMidwest

  Pfizer Inc. Starting to Sell Pain Drug With Acura Pharmaceuticals, Inc. Technology

  January 24, 2012

   · 

  7 min read
• FDA

  Biomomentum Inc. Obtains CE Marking for the Arthro-BST(TM)

  January 24, 2012

   · 

  2 min read
• Business

  Santhera Pharmaceuticals AG and Ipsen Renegotiate Fipamezole Licensing Agreement

  January 24, 2012

   · 

  1 min read
• Biotech Bay

  Kythera Biopharmaceuticals Joins the Content Management Revolution with Veeva Vault

  January 24, 2012

   · 

  1 min read
• Business

  Blueprint Medicines Appoints Oncology Drug Development Leader Christoph Lengauer as Chief Scientific Officer

  January 24, 2012

   · 

  1 min read
• Tobii Technology AB Release: Launch of Tobii X1 Light Eye Tracker Makes Cost-Effective Research in the Field ‘a Snap’

  January 24, 2012

   · 

  1 min read
• Business

  Formula Pharmaceuticals Appoints Martyn Greenacre to Board of Directors

  January 24, 2012

   · 

  1 min read
• Lone Star Bio

  The University of Texas at San Antonio Reports $56.8 Million in Research Spending

  January 24, 2012

   · 

  3 min read
• FDA

  Systagenix Wound Management Announces CE Mark and First Commercial Shipment of WOUNDCHEK™ Protease Status, Making it the World’s First Point-of-care Diagnostic Test for Chronic Wounds

  January 24, 2012

   · 

  4 min read